Skip to main content
OpenTrials
Completed

NCT Number: NCT04309422

Texture Features and PDL1 in CT-PET 18 FDG

Search correlation between texture features in CT-PET 18 FDG and overexpression of PDL1 in non-small cell lung carcinomas during the inital staging.

The hypothesis is that overexpression of PDL1is correlated with at least one texture feature among those selected.

84 CT-PET 18 FDG at the initial staging of a non small cell lung carcinoma (adenocarcinoma or squamous cell carcinoma), whose the biopsed site was the primitive site or the drainage lymphadenopathy, without previous treatment, were recruited and analyzed by a software allowing to estimate texture features.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uh Montpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patient ;
  • first CT-PET 18 FDG realized for the inital staging ;
  • absence of previous treatment for a thoracic neoplasm ;
  • biopsy realized on the primitive site or local drainage lymphadenopathy ;
  • primitive site viewable with morphological imagery ;
  • availability of evaluation of PDL1's overexpression ;

Exclusion criteria

  • Refusal to participate in this research

Treatment and study plan

Primary outcomes

  1. Correlation between at least one texture feature and overexpression of PDL1

    Time frame: 1 day

    Correlation between at least one texture feature and overexpression of PDL1

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Correlation Between Texture Features With CT-PET 18 FDG and Overexpression of PDL1 in Non-small-cell Lung Carcinomas During the Initial Staging.

Important dates

Study start
2018
Primary completion
2018
Study completion
2020
First posted
Mar 16, 2020
Registry last updated
Mar 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.